Key Details
Price
$6.77Annual Revenue
$50.00 MAnnual ROE
-33.44%Beta
1.51Events Calendar
Next earnings date:
May 30, 2025Recent quarterly earnings:
Mar 6, 2025Recent annual earnings:
Mar 6, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Mar 7, 25 Baird
OutperformJan 9, 25 RBC Capital
OutperformNov 7, 24 RBC Capital
OutperformOct 22, 24 Baird
OutperformAug 14, 24 RBC Capital
OutperformApr 30, 24 Stifel
BuyApr 30, 24 RBC Capital
OutperformApr 30, 24 Morgan Stanley
OverweightMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Contineum Therapeutics Class A doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Contineum Therapeutics Class A?
- Does Contineum Therapeutics Class A pay dividends?
- What sector is Contineum Therapeutics Class A in?
- What industry is Contineum Therapeutics Class A in?
- What country is Contineum Therapeutics Class A based in?
- Is Contineum Therapeutics Class A in the S&P 500?
- Is Contineum Therapeutics Class A in the NASDAQ 100?
- Is Contineum Therapeutics Class A in the Dow Jones?
- When was Contineum Therapeutics Class A's last earnings report?
- When does Contineum Therapeutics Class A report earnings?
- Should I buy Contineum Therapeutics Class A stock now?
What is the ticker symbol for Contineum Therapeutics Class A?
The ticker symbol for Contineum Therapeutics Class A is NASDAQ:CTNM
Does Contineum Therapeutics Class A pay dividends?
No, Contineum Therapeutics Class A does not pay dividends
What sector is Contineum Therapeutics Class A in?
Contineum Therapeutics Class A is in the Healthcare sector
What industry is Contineum Therapeutics Class A in?
Contineum Therapeutics Class A is in the Biotechnology industry
What country is Contineum Therapeutics Class A based in?
Contineum Therapeutics Class A is headquartered in United States
Is Contineum Therapeutics Class A in the S&P 500?
No, Contineum Therapeutics Class A is not included in the S&P 500 index
Is Contineum Therapeutics Class A in the NASDAQ 100?
No, Contineum Therapeutics Class A is not included in the NASDAQ 100 index
Is Contineum Therapeutics Class A in the Dow Jones?
No, Contineum Therapeutics Class A is not included in the Dow Jones index
When was Contineum Therapeutics Class A's last earnings report?
Contineum Therapeutics Class A's most recent earnings report was on Mar 6, 2025
When does Contineum Therapeutics Class A report earnings?
The next expected earnings date for Contineum Therapeutics Class A is May 30, 2025
Should I buy Contineum Therapeutics Class A stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions